Stem Cell Selection Unneeded for SSc Transplant Therapy? Small trial suggests a simpler path to defeat systemic sclerosis Dec 03, 2024
HIPEC for Recurrent, Platinum-Sensitive Ovarian Cancer Fails to Improve PFS More favorable-risk patient population may explain variance from other recent studies Dec 03, 2024
Some Older Adults Think Stopping CRC Screening at Age 75 Is 'Unacceptable' Limited life expectancy may not increase acceptance of such guidelines, researchers say Dec 03, 2024
Drug Prices Negotiated by Medicare Still Higher Than Other Countries' All drugs except one remained more expensive in the U.S. Dec 02, 2024
HIV Doesn't Cause AIDS and Other Conspiracies RFK Jr. Endorsed He has also claimed Wi-Fi causes cancer and that antidepressants are to blame for mass shootings Dec 02, 2024
Year in Review: Multiple Myeloma A drug comeback, new FDA approvals, and a new standard for transplant-ineligible patients Dec 02, 2024
Benefits of HPV Vaccination; Contraindications to Newer Obesity Drugs Also in TTHealthWatch: minimum effective dose of pneumococcal vaccines Nov 30, 2024 podcast
Lidocaine Fails to Speed Up Gut Function Recovery After Colonic Surgery Absence of gut function recovery is the primary reason for extended hospital stays Nov 29, 2024
Big Drop in Cervical Cancer Deaths; Publication Hijackers; A Win for CRC Home Tests News, features, and commentary about cancer-related issues Nov 29, 2024
New CAR-T Drug Induces Durable Remissions in ALL, Published Data Show Results of FELIX study supported obecabtagene autoleucel's recent FDA approval Nov 27, 2024
FDA Investigating Blood Cancer Risk With Gene Therapy Skysona Agency is evaluating the need for further regulatory action Nov 27, 2024
TRK Inhibitor Active in Treatment-Refractory Glioblastoma Also from SNO: Encouraging early results with ATM pathway inhibition, sonodynamic therapy Nov 27, 2024
Hit and Miss for CDK4/6 Inhibitor in Recurrent Brain Cancer Abemaciclib active in previously treated meningioma, fails to impress in glioblastoma combination Nov 26, 2024
Preoperative Embolization Linked to Relapse-Free Survival in Meningioma Significant impact on RFS with subtotal resection, and molecular analysis suggests hypoxic effect Nov 25, 2024
Early Promise for PI3K Inhibitor in Brain Metastases Also from SNO: TTFields boosts PFS in glioblastoma, proton therapy for leptomeningeal disease Nov 25, 2024
IDH Inhibitor Activity in Brain Cancer Persists With Longer Follow-Up Two-fold increase in PFS with postoperative ivosidenib holds up in placebo-controlled trial Nov 24, 2024
AMA President-Elect Confronts a New Challenge: A Brain Tumor Bobby Mukkamala, MD, was diagnosed with grade 2 glioma after experiencing aphasia at AMA meeting Nov 22, 2024
Patients With Melanoma Brain Mets May Fare Better With RT Before Immunotherapy Meta-analysis shows better PFS, OS with RT-first approach, but issue requires more study Nov 22, 2024
Major Shifts in Urothelial Cancer Care: Immunotherapy Redefines Standards New treatments reshape metastatic and muscle-invasive bladder cancer therapy Nov 22, 2024 video
Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis? News, features, and commentary about cancer-related issues Nov 22, 2024
Treatment of Oligometastatic EGFR-Mutant Lung Cancer More research needed on role of local therapy in new era of treatment Nov 22, 2024
FDA Approves Zanidatamab for Biliary Tract Cancer New antibody indicated for previously treated, unresectable or metastatic HER2-positive disease Nov 21, 2024
Sacubitril/Valsartan Curbs Cardiotoxicity From Chemotherapy Benefit shown in trial of patients flagged for high risk of cardiotoxicity Nov 20, 2024
Small Benefit, Persistent Toxic Risk With Adjuvant Anthracycline in Breast Cancer Time for "long goodbye" to the "burning red devil," say editorialists Nov 19, 2024
Immunotherapy Shows Promise in Downstaging Liver Tumors Prior to Transplant 78% of patients in prospective study had tumor downstaging with immune checkpoint inhibitors Nov 19, 2024
Does Fluoride Cause Cancer, IQ Loss, and More? Fact-Checking RFK Jr.'s Claims Trump's pick to lead HHS has called the mineral "industrial waste" Nov 18, 2024
FDA Approves First Menin Inhibitor for Acute Leukemia Complete responses in 21% of patients treated with single-agent revumenib Nov 15, 2024
Response Duration After Stopping Enfortumab Vedotin in Bladder Cancer Patients with complete response can have long treatment-free interval, study suggests Nov 15, 2024 video
MEK Inhibitor Scores Big Win in Adults, Children With Neurofibromatosis Type 1 More than 40% of adults, half of children met response criteria, majority of responses durable Nov 15, 2024
Big Comeback for Myeloma Drug; DIY Cancer Therapy; Gut Clues to Bladder Cancer News, features, and commentary about cancer-related issues Nov 15, 2024
Adding HIPEC Boosts Survival in Recurrent Ovarian Cancer Results "signal a paradigm shift," expert says Nov 14, 2024
Accuracy of Skin Cancer Diagnosis Varies by Physician, Exam Method Greatest diagnostic accuracy with experienced dermatologists using dermoscopy Nov 14, 2024
'Full House' Star's Cancer; Fluoride Fears Go Mainstream; Florida Doctor Arrested Health news and commentary gathered by 名媛直播 staff Nov 14, 2024
Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival But absence of significant OS benefit raises questions about long-term benefit, expert says Nov 13, 2024
Targeted Combination Shows Promise in Metastatic Kidney Cancer Other IKCS news: closer look at belzutifan safety, challenges of triplet therapies for RCC Nov 13, 2024
Electronic Symptom Screening in Kids With Cancer Boosts Quality of Care Improvements seen in pain, neuropathy, and cognitive function Nov 13, 2024
Large, Grade 4 Kidney Tumors Pose Risk of Early Cancer-Specific Mortality Possible guidance for use of adjuvant immunotherapy in high-risk, non-metastatic disease Nov 12, 2024
AMA Delegates Want Better Protection From Ionizing Radiation Exposure Delegates express concerns that PPE doesn't always cover women, who are more at risk of exposure Nov 12, 2024
Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy Better OS, PFS, response rate, but newer combination strategies not included Nov 12, 2024
Year in Review: Early Breast Cancer USPSTF screening recommendations, broader indication for ribociclib, OS win for pembrolizumab Nov 12, 2024
